pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
EPKINLY · news · pharmadog
← back to EPKINLY
News mentioning EPKINLY
10
stories
20d
Genmab soars to record highs after cancer drug succeeds in key trial
biopharma dive
21d
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
biospace
21d
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
biospace
23d
Genmab’s ADC beats survival expectations in Phase 3 ovarian cancer trial
biospace
Oct 20, 26
Epkinly data only one of Genmab's make-or-break readouts ahead of steep sales erosion
biospace
Oct 7, 26
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
biospace
Oct 6, 26
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
biopharma dive
Oct 6, 26
AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
biospace
Oct 6, 26
AbbVie, Genmab trot out first-line DLBCL win for Epkinly in challenge to Polivy
endpoints
Jun 30, 26
AbbVie and Genmab's latest win brings Epkinly closer to label expansion
endpoints